1 / 10

Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Revie

This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. Browse full report @ http://bit.ly/1FfHsCY

addyparker2350
Télécharger la présentation

Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Revie

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Category :  Healthcare Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014

  2. Summary Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Biliary Tract Cancers therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Metastatic Biliary Tract Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Biliary Tract Cancer and special features on late-stage and discontinued projects. Browse Complete Report - http://www.aarkstore.com/healthcare/89680/metastatic-biliary-tract-cancer-pipeline-review-h2-2014

  3. Scope - The report provides a snapshot of the global therapeutic landscape of Metastatic Biliary Tract Cancer- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Metastatic Biliary Tract Cancer and enlists all their major and minor projects- The report summarizes all the dormant and discontinued pipeline projects - A review of the Metastatic Biliary Tract Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages

  4. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage- Develop strategic initiatives by understanding the focus areas of leading companies- Identify and understand important and diverse types of therapeutics under development for Metastatic Biliary Tract Cancer- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline- Devise corrective measures for pipeline projects by understanding Metastatic Biliary Tract Cancer pipeline depth and focus of Indication therapeutics

  5. Table of Content Introduction 5Global Markets Direct Report Coverage 5Metastatic Biliary Tract Cancer Overview 6Therapeutics Development 7Pipeline Products for Metastatic Biliary Tract Cancer - Overview 7Pipeline Products for Metastatic Biliary Tract Cancer - Comparative Analysis 8Metastatic Biliary Tract Cancer - Therapeutics under Development by Companies 9Metastatic Biliary Tract Cancer - Pipeline Products Glance 10Clinical Stage Products 10Metastatic Biliary Tract Cancer - Products under Development by Companies 11Metastatic Biliary Tract Cancer - Companies Involved in Therapeutics Development 12AstraZeneca PLC 12GlaxoSmithKline plc 13Novartis AG 14OncoTherapy Science, Inc. 15

  6. List of Tables Number of Products under Development for Metastatic Biliary Tract Cancer, H2 2014 7Number of Products under Development for Metastatic Biliary Tract Cancer - Comparative Analysis, H2 2014 8Number of Products under Development by Companies, H2 2014 9Comparative Analysis by Clinical Stage Development, H2 2014 10Products under Development by Companies, H2 2014 11Metastatic Biliary Tract Cancer - Pipeline by AstraZeneca PLC, H2 2014 12Metastatic Biliary Tract Cancer - Pipeline by GlaxoSmithKline plc, H2 2014 13Metastatic Biliary Tract Cancer - Pipeline by Novartis AG, H2 2014 14Metastatic Biliary Tract Cancer - Pipeline by OncoTherapy Science, Inc., H2 2014 15Assessment by Monotherapy Products, H2 2014 16Assessment by Combination Products, H2 2014 17Number of Products by Stage and Target, H2 2014 19Number of Products by Stage and Mechanism of Action, H2 2014

  7. List of Figures Number of Products under Development for Metastatic Biliary Tract Cancer, H2 2014 7Number of Products under Development for Metastatic Biliary Tract Cancer - Comparative Analysis, H2 2014 8Number of Products under Development by Companies, H2 2014 9Comparative Analysis by Clinical Stage Development, H2 2014 10Assessment by Monotherapy Products, H2 2014 16Number of Products by Top 10 Targets, H2 2014 18Number of Products by Stage and Top 10 Target, H2 2014 19Number of Products by Top 10 Mechanism of Actions, H2 2014 20Number of Products by Stage and Top 10 Mechanism of Actions, H2 2014 21Number of Products by Stage and Top 10 Routes of Administration, H2 2014 22Number of Products by Top 10 Molecule Types, H2 2014 23Number of Products by Stage and Top 10 Molecule Types, H2 2014 24

  8. Related Reports Pancreatitis Global Clinical Trials Review, H2, 2014 Onchocerciasis (River Blindness) Global Clinical Trials Review, H2, 2014 Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2014 Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Global Clinical Trials Review, H2, 2014 Urinary Tract Infections Global Clinical Trials Review, H2, 2014 Vulvovaginal Candidiasis Global Clinical Trials Review, H2, 2014 Pleural Effusion Global Clinical Trials Review, H2, 2014 Febrile Neutropenia Global Clinical Trials Review, H2, 2014 Respiratory Depression Global Clinical Trials Review, H2, 2014

  9. Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014 Published: Dec 2014| 48 Pages Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014, provides an overview of the Metastatic Biliary Tract Cancers therapeutic pipeline. Price

  10. Contact Us Office Office No. - 809, 8th Floor,B-Wing, Mahaavir Icon, Plot No.- 89 & 90, Sector-15,CBD-Belapur, Navi Mumbai – 400614, Maharashtra, India. Telefax No: +91 22 4127 6660 24/7 Online Support: +91 9987295242 General Inquiries : +91 - 22 2756 4953 You Can Visit http://www.aarkstore.com OR Mail us at contact@aarkstore.com Blog : http://www.aarkstore.com/blog/ Conference : http://conference.aarkstore.com/ News : http://www.aarkstore.com/news

More Related